Ibrutinib Blocks CD40 Signalling in CLL in Vivo by Reducing TRAF4 Levels.

Investor logo

Warning

This publication doesn't include Faculty of Medicine. It includes Central European Institute of Technology. Official publication website can be found on muni.cz.

Authors

SHARMA Sonali MLADONICKÁ PAVLASOVÁ Gabriela ŠEDA Václav AMRUZ ČERNÁ Kateřina HOFERKOVÁ Eva FILIP Daniel ONDRIŠOVÁ Laura ŠANDOVÁ Veronika KOŠŤÁLOVÁ Lenka FARIA ZENI Pedro BORSKÝ Marek OPPELT Jan LISKOVA K. KŘEN Leoš JANÍKOVÁ Andrea POSPÍŠILOVÁ Šárka FERNANDES S. SHEHATA M. RASSENTI L. JAEGER U. DOUBEK Michael DAVIDS M. BROWN J. MAYER Jiří KIPPS T. MRÁZ Marek

Year of publication 2021
Type Conference abstract
MU Faculty or unit

Central European Institute of Technology

Citation
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info